Figure 3 shows the immunolabeling area (brown color) in the muscular zone when an antibody against MMP9 was used in a segment of the thoracic aorta from CS and a segment of the TAA from MFS patients (A and B, respectively). Here, MMP9 is linked to Marfan syndrome.